Observational methods in epidemiologic assessment of vaccine effectiveness

Authors

  • Siranda Torvaldsen National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145
  • Peter B McIntyre National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases

DOI:

https://doi.org/10.33321/cdi.2002.26.43

Keywords:

vaccine effectiveness

Abstract

Observational methods are important in the measurement of vaccine effectiveness (VE) as experimental designs cannot be used for measurement of vaccines already on the vaccination schedule. Furthermore, efficacy measured in clinical trials under ideal conditions may differ to effectiveness in the field under non-ideal conditions and in different populations. In addition to post-licensure surveillance, observational VE studies are particularly important when disease incidence does not predictably decrease with increased vaccine coverage, when high proportions of vaccine failure among reported cases suggest a problem with the vaccine or when issues arise that were not predicted in pre-licensure evaluations. Commonly used study types for evaluating VE include cohort studies, household contact studies, case-control studies, the screening method and case-cohort studies. There are many potential biases in all observational VE studies which should be considered in the study design and analysis stage. Of the five observational study types reviewed, cohort studies undertaken during an outbreak investigation offer the simplest means of VE estimation and is the preferred study design where the situation permits. Where this is not possible the screening method is the most economical and rapid method. It is essential that the effectiveness of all vaccination programs be evaluated. As new vaccines are introduced to the schedule, booster doses are added and the timing of doses changed, the role of observational methods in the evaluation of VE will become even more important. To date, few observational VE studies have been undertaken in Australia, suggesting the under-utilisation of these methods. Commun Dis Intell 2002;26:451-457.

Downloads

Download data is not yet available.

References

Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63:1055-1068.

Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988;10:212-241.

Halloran ME, Struchiner CJ, Longini IM. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol 1997;146:789-803.

McIntyre P, Amin J, Gidding H, Hull B, Torvaldsen S, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998. Commun Dis Intell 2000;24 Suppl:S1-S83.

Fine PE, Clarkson JA. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 1987;9:866-883 (Review).

Fine PE. Implications of different study designs for the evaluation of acellular pertussis vaccines. Dev Biol Stand 1997;89:123-133 (Review).

Cherry JD, Olin P. The science and fiction of pertussis vaccines (commentary). Pediatrics 1999;104:1381-1384.

Palmer SR. Vaccine efficacy and control measures in pertussis. Arch Dis Child 1991;66:854-857.

Lister S, McIntyre P, Burgess M, O'Brien ED. Immunisation coverage in Australian children: a systematic review. Commun Dis Intell 1999;23:145-170.

Mühlemann K, Weiss NS. Can herd immunity influence the assessment of vaccine efficacy in nonrandomized studies? (letter). Am J Public Health 1997;87:113.

Chen RT, Orenstein WA. Epidemiologic methods in immunization programs. Epidemiol Rev 1996;18:99-117.

Herceg A. Bordetella pertussis in an ACT school: outbreak investigation and vaccine efficacy study. Commun Dis Intell 1993;17:284-286.

Jeremijenko AM, Kelly H, Patel M. The high morbidity associated with a measles outbreak in a West Australian town. J Paediatr Child Health 1996;32:382-385.

Cheah D, Lane JM, Passaris I. Measles vaccine efficacy study in a Canberra high school: a study following a measles outbreak. J Paediatr Child Health 1993;29:455-458.

Patel M, Lush D. Measles vaccine effectiveness in Central Australian Aboriginal children vaccinated at or after eight months of age. Aust N Z J Public Health 1998;22:729-730.

Gidding HF, Hills S, Selvey L, Roberts LA, Johnston S. An outbreak of measles in a rural Queensland town in 1997; an opportunity to assess vaccine effectiveness. Commun Dis Intell 1999;23:240-245.

Fine PEM, Clarkson JA, Miller E. The efficacy of pertussis vaccines under conditions of household exposure. Int J Epidemiol 1988;17:635-642.

Schlesselman JJ. Case-control Studies. Design, Conduct, Analysis. New York: Oxford University Press, 1982.

McDonnell LF, Jorm L, Patel MS. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate? Med J Aust 1995;162:471-475.

Bower C, Condon R, Payne J, Burton P, Watson C, et al. Measuring the impact of conjugate vaccines on invasive Haemophilus influenzae type b infection in Western Australia. Aust N Z J Public Health 1998;22:67-72.

Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993;22:742-746.

de Melker HE, Schellekens JFP, Neppeelenbroek SE, Mooi FR, Rümke HC, et al. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000;6:348-357.

Guris D, Strebel PM, Tachdjian R, Bardenheier B, Wharton M, et al. Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994. J Infect Dis 1997;176:456-463.

Halperin SA, Bortolussi R, MacLean D, Chisholm N. Persistence of pertussis in an immunized population: results of the Nova Scotia enhanced pertussis surveillance program. J Pediatr 1989;115:686-693.

Ramsay M, Farrington C, Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect 1993;111:41-48.

Blakely T, Mansoor O, Baker M. The 1996 pertussis epidemic in New Zealand: vaccine effectiveness. N Z Med J 1999;112:118-120.

Herceg A. The decline of Haemophilus influenzae type b disease in Australia. Commun Dis Intell 1997;21:173-176.

Torvaldsen S, Simpson JM, McIntyre PB. Effectiveness of pertussis vaccination in New South Wales, Australia, 1996 to 1998. Eur J Epidemiol; In press.

Smith PG, Rodigues LC, Fine PEM. Assessing the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol 1984;13:87-93

Downloads

Published

01/09/02

How to Cite

Torvaldsen, Siranda, and Peter B McIntyre. 2002. “Observational Methods in Epidemiologic Assessment of Vaccine Effectiveness”. Communicable Diseases Intelligence 26 (September):451-57. https://doi.org/10.33321/cdi.2002.26.43.

Issue

Section

Original article

Categories

Most read articles by the same author(s)

1 2 3 4 5 > >>